The Catalytic Mechanism of Nuclear Premessenger RNA Splicing by the Spliceosome

剪接体对核前信使RNA剪接的催化机制

基本信息

  • 批准号:
    8788330
  • 负责人:
  • 金额:
    $ 54.09万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-24 至 2018-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Our long-term goal is to elucidate the mechanisms by which the spliceosome catalyzes pre-mRNA splicing and in particular to define the structural and functional role of RNA and protein in catalysis. Catalysis of pre-mRNA splicing by the spliceosome is a defining feature of eukaryotes. In humans, catalysis is required to excise ten introns on average for nearly every gene, and catalysis at alternative sites expands the proteome and contributes to the complexity of higher eukaryotes. Indeed, mutations in at least 15% of human diseases result from errors in splicing. Despite this importance of pre-mRNA splicing to eukaryotic gene expression, for decades our understanding of splicing catalysis has languished, particularly in comparison to our understanding of catalysis at the two other major stages of gene expression - transcription and translation. We have not even known whether catalysis is mediated by the RNA or protein parts of the spliceosome. However, through our collaborative efforts, we have recently provided definitive evidence that the RNA parts catalyze splicing, positioning two divalent metal ions for interaction with the scissile phosphates. Strikingly, our work also establishes that the spliceosome utilizes a catalytic mechanism indistinguishable from the catalytic mechanism of self-splicing group II RNA introns, extending the parallels with the group II intron to the atomic level at the catalytic core and providing strog support for the hypothesis that these two enzymes share common evolutionary origins. Despite this advance and other achievements in the field, many fundamental questions remain. For example, how are the nucleophiles in either splicing system activated for catalysis, how does the architecture of the spliceosomal catalytic core position the reactive sites for catalysis, and what is the role of protein in mediating RNA-based catalysis? To answer these questions, we aim to test a metal cluster model for catalysis of nuclear pre-mRNA splicing, to define the architecture and dynamics of the catalytic core of the spliceosome, and to define the essential role of protein in assisting RNA-based splicing catalysis. We will accomplish these aims through a continuation of our unique and synergistic collaboration that allows for a combined approach of chemistry, biochemistry and molecular genetics. This work will transform our understanding of the roles of RNA and protein in spliceosomal catalysis, with significant implications for understanding the origins and evolution of the spliceosome.
描述(由申请人提供):我们的长期目标是阐明剪接体催化pre-mRNA剪接的机制,特别是定义RNA和蛋白质在催化中的结构和功能作用。剪接体催化前mrna剪接是真核生物的一个重要特征。在人类中,几乎每个基因平均需要催化去除10个内含子,并且在替代位点的催化扩展了蛋白质组,并有助于高级真核生物的复杂性。事实上,至少15%的人类疾病的突变是由剪接错误造成的。尽管pre-mRNA剪接对真核基因表达具有重要意义,但几十年来,我们对剪接催化的理解却有所下降,特别是与我们对基因表达的另外两个主要阶段-转录和翻译的催化的理解相比。我们甚至不知道催化作用是由剪接体的RNA部分还是蛋白质部分介导的。然而,通过我们的合作努力,我们最近提供了明确的证据,证明RNA部分催化剪接,定位两个二价金属离子与可剪切磷酸盐相互作用。引人注目的是,我们的工作还建立了剪接体利用与自剪接II组RNA内含子的催化机制难以区分的催化机制,将与II组内含子的相似之处扩展到催化核心的原子水平,并为这两种酶具有共同进化起源的假设提供了强有力的支持。尽管这一领域取得了进展和其他成就,但仍存在许多基本问题。例如,剪接系统中的亲核试剂是如何被激活进行催化的,剪接体催化核心的结构是如何定位催化反应位点的,以及蛋白质在介导rna催化中的作用是什么?为了回答这些问题,我们的目标是测试核前mrna剪接催化的金属簇模型,定义剪接体催化核心的结构和动力学,并定义蛋白质在协助rna剪接催化中的重要作用。我们将通过继续我们独特的协同合作,允许化学,生物化学和分子遗传学的结合方法来实现这些目标。这项工作将改变我们对RNA和蛋白质在剪接体催化中的作用的理解,对理解剪接体的起源和进化具有重要意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joseph Anthony Piccirilli其他文献

Joseph Anthony Piccirilli的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joseph Anthony Piccirilli', 18)}}的其他基金

Structure and Function of Non-Coding RNA
非编码RNA的结构和功能
  • 批准号:
    10623993
  • 财政年份:
    2023
  • 资助金额:
    $ 54.09万
  • 项目类别:
The VS Ribozyme: Catalytic Mechanism, Transition State Structure, and Evolution
VS 核酶:催化机制、过渡态结构和进化
  • 批准号:
    10305610
  • 财政年份:
    2019
  • 资助金额:
    $ 54.09万
  • 项目类别:
The VS Ribozyme: Catalytic Mechanism, Transition State Structure, and Evolution
VS 核酶:催化机制、过渡态结构和进化
  • 批准号:
    10582360
  • 财政年份:
    2019
  • 资助金额:
    $ 54.09万
  • 项目类别:
The VS Ribozyme: Catalytic Mechanism, Transition State Structure, and Evolution
VS 核酶:催化机制、过渡态结构和进化
  • 批准号:
    10061618
  • 财政年份:
    2019
  • 资助金额:
    $ 54.09万
  • 项目类别:
CHAPERONE-ASSISTED RNA CRYSTALLOGRAPHY - Resubmission 01
伴侣辅助 RNA 晶体学 - 重新提交 01
  • 批准号:
    8506004
  • 财政年份:
    2013
  • 资助金额:
    $ 54.09万
  • 项目类别:
Chaperone-Assisted RNA Crystallography
分子伴侣辅助 RNA 晶体学
  • 批准号:
    10058842
  • 财政年份:
    2013
  • 资助金额:
    $ 54.09万
  • 项目类别:
CHAPERONE-ASSISTED RNA CRYSTALLOGRAPHY - Resubmission 01
伴侣辅助 RNA 晶体学 - 重新提交 01
  • 批准号:
    9037690
  • 财政年份:
    2013
  • 资助金额:
    $ 54.09万
  • 项目类别:
CHAPERONE-ASSISTED RNA CRYSTALLOGRAPHY - Resubmission 01
伴侣辅助 RNA 晶体学 - 重新提交 01
  • 批准号:
    8643797
  • 财政年份:
    2013
  • 资助金额:
    $ 54.09万
  • 项目类别:
Chaperone-Assisted RNA Crystallography-Equipment Supplement
分子伴侣辅助 RNA 晶体学设备补充品
  • 批准号:
    9895189
  • 财政年份:
    2013
  • 资助金额:
    $ 54.09万
  • 项目类别:
Investigating the Catalytic Mechanism of the HDV Ribozyme
HDV 核酶催化机制的研究
  • 批准号:
    8465171
  • 财政年份:
    2010
  • 资助金额:
    $ 54.09万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 54.09万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.09万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 54.09万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.09万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 54.09万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.09万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 54.09万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 54.09万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 54.09万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.09万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了